Surajit Mistry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Surajit Mistry has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Nilendu Jyoti Maitra
Deputy Director of Research, Extension and Firms, West Bengal University of Animal & Fishery Sciences, Kolkata, West Bengal, India
5 shared publicationsRajiv Roy
Department of Orthopaedics Calcutta National Medical College and Hospital Kolkata West Bengal India
5 shared publicationsSubhasis Roy
Department of VCC (Veterinary Surgery and Radiology) West Bengal University of Animal and Fishery Sciences Kolkata West Bengal India
5 shared publicationsAbhijit Chanda
School of Bio-Science & Engineering, Jadavpur University, Kolkata, 734432, India
4 shared publicationsSomeswar Datta
Bioceramics and Coating Division, CSIR-Central Glass & Ceramic Research Institute, Govt. of India, Kolkata, West Bengal Pin- 700032, India
4 shared publicationsSubhasish Burman
Department of Oral & Maxillofacial Surgery, Burdwan Dental College & Hospital, Powerhouse Para, West Bengal 713101, India
3 shared publications
Latest Publications
- 12 October 2026
- Published by Wiley in Oral Diseases
Effects of Antimicrobial Mouthwashes on Oral Health and Blood Pressure: A Preliminary Parallel Randomized Controlled Trial
Objective: Although antimicrobial mouthwashes vary in efficacy and safety for managing biofilm‐induced gingivitis, concerns remain regarding their potential to reduce nitric oxide bioavailability and increase hypertension risk. Therefore, we investigated whether octenidine is more effective and causes fewer adverse events than chlorhexidine, and whether antimicrobial mouthwash use increases hypertension risk. Methods: In this parallel randomized controlled trial, 90 participants were randomly allocated (1:1:1) to rinse with 10 mL of 2% saline (Group I), 0.2% chlorhexidine (Group II), or 0.1% octenidine (Group III) for 21 days. Co‐primary outcomes (clinical parameters and blood pressure) and secondary outcomes (salivary bacterial count, adverse events, and pulse pressure) were assessed over 42 days. Results: At day 22, antimicrobial mouthwashes significantly reduced clinical (29%–52%) and microbial (> 92%) measures ( p < 0.001), whereas saline produced minimal changes ( p > 0.05). Salivary nitrate levels showed the opposite trend. Groups II and III showed comparable efficacy, but octenidine was associated with fewer adverse events. Although systolic blood pressure increased slightly in all groups, the changes were clinically insignificant. Elevated pulse pressure in antimicrobial groups returned to baseline by Day 42. Conclusions: Octenidine (0.1%) was safer and comparably effective to chlorhexidine. Short‐term antimicrobial mouthwash had no clinically significant effect on blood pressure. Trial Registration: CTRI/2024/08/072091 (India), date: 07/08/2024. URL: https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=MTEwOTY5&Enc
- 12 October 2026
- Published by Wiley in Oral Diseases
Effects of Antimicrobial Mouthwashes on Oral Health and Blood Pressure: A Preliminary Parallel Randomized Controlled Trial
Objective: Although antimicrobial mouthwashes vary in efficacy and safety for managing biofilm‐induced gingivitis, concerns remain regarding their potential to reduce nitric oxide bioavailability and increase hypertension risk. Therefore, we investigated whether octenidine is more effective and causes fewer adverse events than chlorhexidine, and whether antimicrobial mouthwash use increases hypertension risk. Methods: In this parallel randomized controlled trial, 90 participants were randomly allocated (1:1:1) to rinse with 10 mL of 2% saline (Group I), 0.2% chlorhexidine (Group II), or 0.1% octenidine (Group III) for 21 days. Co‐primary outcomes (clinical parameters and blood pressure) and secondary outcomes (salivary bacterial count, adverse events, and pulse pressure) were assessed over 42 days. Results: At day 22, antimicrobial mouthwashes significantly reduced clinical (29%–52%) and microbial (> 92%) measures ( p < 0.001), whereas saline produced minimal changes ( p > 0.05). Salivary nitrate levels showed the opposite trend. Groups II and III showed comparable efficacy, but octenidine was associated with fewer adverse events. Although systolic blood pressure increased slightly in all groups, the changes were clinically insignificant. Elevated pulse pressure in antimicrobial groups returned to baseline by Day 42. Conclusions: Octenidine (0.1%) was safer and comparably effective to chlorhexidine. Short‐term antimicrobial mouthwash had no clinically significant effect on blood pressure. Trial Registration: CTRI/2024/08/072091 (India), date: 07/08/2024. URL: https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=MTEwOTY5&Enc
- 24 December 2024
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 113 (1) , e37858
Investigation of Antibiotic‐Releasing Biodegradable Composite Bone Cements for Treating Experimental Chronic Maxillofacial Bone Infection
Chronic osteomyelitis of the maxillofacial bones (i.e., jaw bones) is a persistent infection that requires effective treatment. Because systemic antibiotics seldom reach necrotic areas to remove bone infection, local antibiotic carriers such as antibiotic‐loaded bone cement can be tried. It is critical to assess the biosafety and efficacy of two new antibiotic‐loaded biodegradable composite bone cements for treating chronic mandibular osteomyelitis, and their drug eluting efficiency and other relevant aspects prior to clinical trial. The physico‐mechanical properties, and drug release capacity of the cements were determined to be suitable for in vivo application. After inducing chronic osteomyelitis with Staphylococcal strains in 30 female rabbit mandibles, bioactive glass composite cement (0.5 g) and biphasic calcium phosphate composite cement (0.5 g) were implanted in 18 defects (nine/test group) for 84 days to compare the therapeutic efficacy with traditional therapy (control, debridement plus antibiotics in nine defects) using microscopic, micrographic, and radiological examination. Antibiotic concentrations in bone (vancomycin: 34.7–53.2 μg/g, tobramycin: 2.1–2.87 μg/g) after 21 days of installation for both cements were sufficient to eradicate pathogens without causing adverse events. In vivo tests suggest that cement groups outperformed (p < 0.05) traditional therapy in terms of infection clearance and osteoconduction. The gross histologic and micrographic scores of biphasic calcium phosphate composite cement (10.33 ± 0.58 and 8.33 ± 1.53, respectively) indicated that the cement barely surpassed (p > 0.05) the other composite cement (12.67 ± 1.53 and 10.0 ± 1.0, respectively). These findings emphasize the potential of antibiotic loaded composite cements as an effective treatment option for chronic maxillofacial osteomyelitis, offering a safer and more efficient alternative to traditional therapy.
- 24 December 2024
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 113 (1) , e37858
Investigation of Antibiotic‐Releasing Biodegradable Composite Bone Cements for Treating Experimental Chronic Maxillofacial Bone Infection
Chronic osteomyelitis of the maxillofacial bones (i.e., jaw bones) is a persistent infection that requires effective treatment. Because systemic antibiotics seldom reach necrotic areas to remove bone infection, local antibiotic carriers such as antibiotic‐loaded bone cement can be tried. It is critical to assess the biosafety and efficacy of two new antibiotic‐loaded biodegradable composite bone cements for treating chronic mandibular osteomyelitis, and their drug eluting efficiency and other relevant aspects prior to clinical trial. The physico‐mechanical properties, and drug release capacity of the cements were determined to be suitable for in vivo application. After inducing chronic osteomyelitis with Staphylococcal strains in 30 female rabbit mandibles, bioactive glass composite cement (0.5 g) and biphasic calcium phosphate composite cement (0.5 g) were implanted in 18 defects (nine/test group) for 84 days to compare the therapeutic efficacy with traditional therapy (control, debridement plus antibiotics in nine defects) using microscopic, micrographic, and radiological examination. Antibiotic concentrations in bone (vancomycin: 34.7–53.2 μg/g, tobramycin: 2.1–2.87 μg/g) after 21 days of installation for both cements were sufficient to eradicate pathogens without causing adverse events. In vivo tests suggest that cement groups outperformed (p < 0.05) traditional therapy in terms of infection clearance and osteoconduction. The gross histologic and micrographic scores of biphasic calcium phosphate composite cement (10.33 ± 0.58 and 8.33 ± 1.53, respectively) indicated that the cement barely surpassed (p > 0.05) the other composite cement (12.67 ± 1.53 and 10.0 ± 1.0, respectively). These findings emphasize the potential of antibiotic loaded composite cements as an effective treatment option for chronic maxillofacial osteomyelitis, offering a safer and more efficient alternative to traditional therapy.
- 2 December 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (1) , 53-62
A two-step hydrothermal method for micro/nanotextured titanium implants and their integration outcomes in goat mandible
A crucial aspect of contemporary dental implant research is modifying implant microdesign to achieve early and robust osseointegration. This study describes a new facile subtraction approach for microdesign modification of titanium implants using akali-hydrothermal followed by ion-exchange reaction (AHIE) in a salt solution, and compares osseointegration performance to machined titanium alloy (negative control) implants. The morphology, wettability, and roughness of the implant surfaces were evaluated. Twenty-four cylinders (two types/side) were inserted into the right and left mandibles of six Bengal goats in opposite order. The implant-bone interface was examined at 8 and 16 weeks following implantation using radiography, micro-computed tomography, histology, and scanning electron microscopy. After AHIE treatment, average surface roughness increased marginally (p > 0.05) due to predominantly micron-scale with random nano-scale alterations, whereas wettability improved substantially (p < 0.05). In addition to micro/nano-scale defects, the AHIE treatment produced few honeycomb-like surface patterns. The AHIE implants demonstrated early and direct bone to implant body contact, and achieved stronger bone fixation in vivo than machined implants. Based on laboratory and in vivo data, we conclude that AHIE processing of titanium implants may be a promising technique for improving surface quality while assuring secure and effective osseointegration for dental implant.
- 2 December 2024
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (1) , 53-62
A two-step hydrothermal method for micro/nanotextured titanium implants and their integration outcomes in goat mandible
A crucial aspect of contemporary dental implant research is modifying implant microdesign to achieve early and robust osseointegration. This study describes a new facile subtraction approach for microdesign modification of titanium implants using akali-hydrothermal followed by ion-exchange reaction (AHIE) in a salt solution, and compares osseointegration performance to machined titanium alloy (negative control) implants. The morphology, wettability, and roughness of the implant surfaces were evaluated. Twenty-four cylinders (two types/side) were inserted into the right and left mandibles of six Bengal goats in opposite order. The implant-bone interface was examined at 8 and 16 weeks following implantation using radiography, micro-computed tomography, histology, and scanning electron microscopy. After AHIE treatment, average surface roughness increased marginally (p > 0.05) due to predominantly micron-scale with random nano-scale alterations, whereas wettability improved substantially (p < 0.05). In addition to micro/nano-scale defects, the AHIE treatment produced few honeycomb-like surface patterns. The AHIE implants demonstrated early and direct bone to implant body contact, and achieved stronger bone fixation in vivo than machined implants. Based on laboratory and in vivo data, we conclude that AHIE processing of titanium implants may be a promising technique for improving surface quality while assuring secure and effective osseointegration for dental implant.
- 22 April 2022
- Published by Elsevier in Journal of Controlled Release
- Vol. 346, 180-192
Treatment of long bone infection by a biodegradable bone cement releasing antibiotics in human
- 22 April 2022
- Published by Elsevier in Journal of Controlled Release
- Vol. 346, 180-192
Treatment of long bone infection by a biodegradable bone cement releasing antibiotics in human
- Open Access
- 3 March 2021
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 12 (1) , 164-177
Biological analysis of an innovative biodegradable antibiotic eluting bioactive glass/gypsum composite bone cement for treating experimental chronic MRSA osteomyelitis
- 3 March 2021
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 12 (1) , 164-177
Open AccessBiological analysis of an innovative biodegradable antibiotic eluting bioactive glass/gypsum composite bone cement for treating experimental chronic MRSA osteomyelitis
- 12 August 2020
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 35 (7) , 799-813
Surface characteristics of titanium dental implants with improved microdesigns: An in vivo study of their osseointegration performance in goat mandible
Current trends in endosseous implant research are focused on the modification of microdesign of implants to achieve early and strong osseointegration. This study compares the influence of zinc doped hydroxyapatite (ZnHAp) coated, hydrothermally treated (HT) and machined Ti6Al4V (control) implants on osseointegration. The surface characterisation and microbial affinity test for implants were performed. Twenty seven (27) cylinders (3 types in each animal) were placed in the mandible of 9 black Bengal goats. Bone-implant interface was examined with histological, radiological parameters and scanning electron microscopy at 6, 12, and 24 weeks post-implantation. Surface roughness alterations of bone-separated implants were analysed by non-contact profilometer with time. The ZnHAp coated implants revealed direct and early bone-implant contact but high bacterial adherence and coating cracks. Low bacterial affinity and early strong bony integration was observed with HT implants. Poor bacterial affinity and delayed but strong fixation was evident with control implants. Based on the results of laboratory and animal experiments, we conclude that the hydrothermal modification of titanium implant is the more suitable way to achieve safe and effective osseointegration than the other two implant types for endosseous application.
- 12 August 2020
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 35 (7) , 799-813
Surface characteristics of titanium dental implants with improved microdesigns: An in vivo study of their osseointegration performance in goat mandible
Current trends in endosseous implant research are focused on the modification of microdesign of implants to achieve early and strong osseointegration. This study compares the influence of zinc doped hydroxyapatite (ZnHAp) coated, hydrothermally treated (HT) and machined Ti6Al4V (control) implants on osseointegration. The surface characterisation and microbial affinity test for implants were performed. Twenty seven (27) cylinders (3 types in each animal) were placed in the mandible of 9 black Bengal goats. Bone-implant interface was examined with histological, radiological parameters and scanning electron microscopy at 6, 12, and 24 weeks post-implantation. Surface roughness alterations of bone-separated implants were analysed by non-contact profilometer with time. The ZnHAp coated implants revealed direct and early bone-implant contact but high bacterial adherence and coating cracks. Low bacterial affinity and early strong bony integration was observed with HT implants. Poor bacterial affinity and delayed but strong fixation was evident with control implants. Based on the results of laboratory and animal experiments, we conclude that the hydrothermal modification of titanium implant is the more suitable way to achieve safe and effective osseointegration than the other two implant types for endosseous application.
- Open Access
- 1 July 2012
- Published by Georg Thieme Verlag KG in European Journal of Dentistry
- Vol. 06 (03) , 324-329
Oral contraceptive pill induced periodontal endocrinopathies and its management: A case report
The purpose of this article is to report a case of unusual oral contraceptive induced periodontal endocrinopathies and its treatment approach. A 32-year-old female patient, having fair oral hygiene, presented with painless, soft, diffuse gingival enlargement on severely compromised periodontium (≥ 4 mm generalized alveolar bone loss and attachment loss). The patient had on oral contraceptive over five years that was discontinued six months ago. When the lesion was not reversed following withdrawal of the pill or by repeated non-surgical measures, biopsy was performed to establish the diagnosis that revealed microscopic findings similar to that seen in gingival enlargement in pregnancy. Pocket depth, tooth mobility and gingival enlargement were reduced remarkably following periodontal surgery. After surgical intervention, close follow-up for over three years revealed no evidence of recurrence of gingival enlargement and progressive attachment loss. We conclude that periodontal surgery, patient compliance and comprehensive maintenance care are effective to return healthy periodontal status in such conditions. (Eur J Dent 2012;6:324-329)
- 1 July 2012
- Published by Georg Thieme Verlag KG in European Journal of Dentistry
- Vol. 06 (03) , 324-329
Open AccessOral contraceptive pill induced periodontal endocrinopathies and its management: A case report
The purpose of this article is to report a case of unusual oral contraceptive induced periodontal endocrinopathies and its treatment approach. A 32-year-old female patient, having fair oral hygiene, presented with painless, soft, diffuse gingival enlargement on severely compromised periodontium (≥ 4 mm generalized alveolar bone loss and attachment loss). The patient had on oral contraceptive over five years that was discontinued six months ago. When the lesion was not reversed following withdrawal of the pill or by repeated non-surgical measures, biopsy was performed to establish the diagnosis that revealed microscopic findings similar to that seen in gingival enlargement in pregnancy. Pocket depth, tooth mobility and gingival enlargement were reduced remarkably following periodontal surgery. After surgical intervention, close follow-up for over three years revealed no evidence of recurrence of gingival enlargement and progressive attachment loss. We conclude that periodontal surgery, patient compliance and comprehensive maintenance care are effective to return healthy periodontal status in such conditions. (Eur J Dent 2012;6:324-329)
- Open Access
- 1 January 2012
- Published by Medknow in Journal of Indian Society of Periodontology
- Vol. 16 (2) , 241-6
Effects of bioactive glass, hydroxyapatite and bioactive glass - Hydroxyapatite composite graft particles in the treatment of infrabony defects
Background: Several synthetic alloplastic materials have been used in the past as an implant in infrabony defects with a goal to reconstruct the lost part of attachment apparatus via new osseous tissue formation. The present study was undertaken to evaluate and compare clinico-radiographically, the effect of bioactive glass (BG), hydroxyapatite (HA), and BG-HA composite bone graft particles in the treatment of human infra-bony periodontal defects. Materials and Methods: Indigenous synthetic HA, BG, and BG-HA composite bone graft materials were developed in the laboratory. Twenty eight infrabony periodontal defects were equally distributed (i.e., seven defects) into four groups. The defects were treated separately with three types of graft materials and non-grafted manner (open flap debridement alone, control) to evaluate both the soft and hard tissue responses after six months of surgery. Evaluation was done by studying different parameters such as plaque index, gingival index, relative attachment level, probing pocket depth, and radiographic bone fill in Intra Oral Peri-Apical radiograph. Results: The healing of defects was uneventful and free of any biological complications. The gain in relative attachment level, reduction of probing pocket depth, and bone fill was statistically significant in all four groups. BG and BG-HA synthetic bone graft implanted sites showed significant bone fill (P<0.05) than hydroxyapatite and unimplanted control sites. Conclusion: The performance of BG and its composite was better compared to HA and open flap debridement alone for the reconstruction of infrabony defects. The BG-HA composite particles may effectively be used as an alternative bone graft material for infrabony defects.
- 1 January 2012
- Published by Medknow in Journal of Indian Society of Periodontology
- Vol. 16 (2) , 241-6
Open AccessEffects of bioactive glass, hydroxyapatite and bioactive glass - Hydroxyapatite composite graft particles in the treatment of infrabony defects
Background: Several synthetic alloplastic materials have been used in the past as an implant in infrabony defects with a goal to reconstruct the lost part of attachment apparatus via new osseous tissue formation. The present study was undertaken to evaluate and compare clinico-radiographically, the effect of bioactive glass (BG), hydroxyapatite (HA), and BG-HA composite bone graft particles in the treatment of human infra-bony periodontal defects. Materials and Methods: Indigenous synthetic HA, BG, and BG-HA composite bone graft materials were developed in the laboratory. Twenty eight infrabony periodontal defects were equally distributed (i.e., seven defects) into four groups. The defects were treated separately with three types of graft materials and non-grafted manner (open flap debridement alone, control) to evaluate both the soft and hard tissue responses after six months of surgery. Evaluation was done by studying different parameters such as plaque index, gingival index, relative attachment level, probing pocket depth, and radiographic bone fill in Intra Oral Peri-Apical radiograph. Results: The healing of defects was uneventful and free of any biological complications. The gain in relative attachment level, reduction of probing pocket depth, and bone fill was statistically significant in all four groups. BG and BG-HA synthetic bone graft implanted sites showed significant bone fill (P<0.05) than hydroxyapatite and unimplanted control sites. Conclusion: The performance of BG and its composite was better compared to HA and open flap debridement alone for the reconstruction of infrabony defects. The BG-HA composite particles may effectively be used as an alternative bone graft material for infrabony defects.